Citations (71)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Sarbajit Ray, Suchetana Gupta, Gayatri Panda, Prarthana Chatterjee, Anoushka Das, Purvi Patawri, Parisa Hosseinzadeh, Arjun Ray & Satarupa Banerjee. (2023) Identification of pseudobaptigenin as a novel polyphenol-based multi-target antagonist of different hormone receptors for breast cancer therapeutics. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-13.
Read now
Read now
Akshita Gupta & Yatender Kumar. (2020) Bispecific antibodies: a novel approach for targeting prominent biomarkers. Human Vaccines & Immunotherapeutics 16:11, pages 2831-2839.
Read now
Read now
Ram Sharma & Vikas Jaitak. (2020) Asparagus racemosus (Shatavari) targeting estrogen receptor α: - An in-vitro and in-silico mechanistic study. Natural Product Research 34:11, pages 1571-1574.
Read now
Read now
Rani J. Qasem. (2020) The estrogenic activity of resveratrol: a comprehensive review of in vitro and in vivo evidence and the potential for endocrine disruption. Critical Reviews in Toxicology 50:5, pages 439-462.
Read now
Read now
Michael J. Duffy & John Crown. (2014) Precision treatment for cancer: Role of prognostic and predictive markers. Critical Reviews in Clinical Laboratory Sciences 51:1, pages 30-45.
Read now
Read now
Kelly T Huynh, Kelly K Chong, Edward S Greenberg & Dave SB Hoon. (2012) Epigenetics of estrogen receptor-negative primary breast cancer. Expert Review of Molecular Diagnostics 12:4, pages 371-382.
Read now
Read now
Articles from other publishers (65)
Fan Dong, Wenjing Guo, Jie Liu, Liang Xu, Myeongsang Lee, Meng Song, Zoe Li, Tucker A. Patterson & Huixiao Hong. 2024. QSAR in Safety Evaluation and Risk Assessment. QSAR in Safety Evaluation and Risk Assessment
259
272
.
Sandip Narayan Wagh & Vivekanand Arvind Chatpalliwar. (2023) Design, Docking, In silico ADME Prediction of Novel 2-substituted-5-
hydroxy-1-(1-methyl-3-morpholinopropyl)-1H-indole-3-carboxamide Derivatives
for Estrogen Receptor Alfa in AF-2 Domain for Effective Anticancer
Treatment. Letters in Drug Design & Discovery 20:8, pages 1066-1085.
Crossref
Crossref
Weiqiang Xiao, Xiaoli Chai, Shengji Jiang & Zhibai Huang. (2022) Optimization modeling of anti breast cancer drug candidates based on data mining. Optimization modeling of anti breast cancer drug candidates based on data mining.
Muhammed Gömeç, Koray Sayin, Mustafa Özkaraca & Hüseyin Özden. (2022) Synthesis, in silico and investigation of anti-breast cancer activity of new diphenyl urea derivatives: Experimental and computational study. Journal of Molecular Structure 1265, pages 133414.
Crossref
Crossref
Zhibai Huang, Shengji Jiang & Weiqiang Xiao. (2022) Optimization Method of an Antibreast Cancer Drug Candidate Based on Machine Learning. Computational and Mathematical Methods in Medicine 2022, pages 1-13.
Crossref
Crossref
Dilawar Khan & Mudassir Khan. 2022. Cancer Biomarkers in Diagnosis and Therapeutics. Cancer Biomarkers in Diagnosis and Therapeutics
201
227
.
Xi Chen, Xu Shi, Andrew F. Neuwald, Leena Hilakivi-Clarke, Robert Clarke & Jianhua Xuan. (2021) ChIP-BIT2: a software tool to detect weak binding events using a Bayesian integration approach. BMC Bioinformatics 22:1.
Crossref
Crossref
Irina Kareva & Joel S. Brown. (2021) Estrogen as an Essential Resource and the Coexistence of ER+ and ER– Cancer Cells. Frontiers in Ecology and Evolution 9.
Crossref
Crossref
Kusal T.G. Samarasinghe & Craig M. Crews. (2021) Targeted protein degradation: A promise for undruggable proteins. Cell Chemical Biology 28:7, pages 934-951.
Crossref
Crossref
Nitish Kumar, Harmandeep Kaur Gulati, Aakriti Sharma, Shilpa Heer, Anupmjot Kaur Jassal, Lovenish Arora, Simranpreet Kaur, Atamjit Singh, Kavita Bhagat, Arshmeet Kaur, Harbinder Singh, Jatinder Vir Singh & Preet Mohinder Singh Bedi. (2020) Most recent strategies targeting estrogen receptor alpha for the treatment of breast cancer. Molecular Diversity 25:1, pages 603-624.
Crossref
Crossref
Mei Wang, Yanyan Zhang, Zhi Xu, Peipei Qian, Wenbo Sun, Xiumei Wang, Zhang Jian, Tiansong Xia, Yong Xu & Jinhai Tang. (2020) RelB sustains endocrine resistant malignancy: an insight of noncanonical NF-κB pathway into breast Cancer progression. Cell Communication and Signaling 18:1.
Crossref
Crossref
Sun Tae Hwang, Min Hee Yang, Seung Ho Baek, Jae-Young Um & Kwang Seok Ahn. (2020) Genistin attenuates cellular growth and promotes apoptotic cell death breast cancer cells through modulation of ERalpha signaling pathway. Life Sciences 263, pages 118594.
Crossref
Crossref
Elif Zeynep Yilmaz & Ebru Esin Yoruker. 2020. Precision Medicine in Oncology. Precision Medicine in Oncology
157
201
.
Boris Itkin, Alastair Breen, Lyudmila Turyanska, Eduardo Omar Sandes, Tracey D. Bradshaw & Andrea Irene Loaiza-Perez. (2020) New Treatments in Renal Cancer: The AhR Ligands. International Journal of Molecular Sciences 21:10, pages 3551.
Crossref
Crossref
Jennifer R. Baker, Jennette A. Sakoff & Adam McCluskey. (2019) The aryl hydrocarbon receptor (AhR) as a breast cancer drug target. Medicinal Research Reviews 40:3, pages 972-1001.
Crossref
Crossref
Xiumei Wang, Yao Fang, Wenbo Sun, Zhi Xu, Yanyan Zhang, Xiaowei Wei, Xuansheng Ding & Yong Xu. (2020) Endocrinotherapy resistance of prostate and breast cancer: Importance of the NF‑κB pathway (Review). International Journal of Oncology.
Crossref
Crossref
Maha Sellami & Nicola Luigi Bragazzi. (2020) Nutrigenomics and Breast Cancer: State-of-Art, Future Perspectives and Insights for Prevention. Nutrients 12:2, pages 512.
Crossref
Crossref
Neda Kasiri, Mahshid Rahmati, Leila Ahmadi, Nahid Eskandari & Hossein Motedayyen. (2019) Therapeutic potential of quercetin on human breast cancer in different dimensions. Inflammopharmacology 28:1, pages 39-62.
Crossref
Crossref
Lara Costantini, Romina Molinari, Barbara Farinon & Nicolò Merendino. (2020) Retinoic Acids in the Treatment of Most Lethal Solid Cancers. Journal of Clinical Medicine 9:2, pages 360.
Crossref
Crossref
Michele Carugno, Cristina Maggioni, Eleonora Crespi, Matteo Bonzini, Simone Cuocina, Laura Dioni, Letizia Tarantini, Dario Consonni, Luca Ferrari & Angela Cecilia Pesatori. (2019) Night Shift Work, DNA Methylation and Telomere Length: An Investigation on Hospital Female Nurses. International Journal of Environmental Research and Public Health 16:13, pages 2292.
Crossref
Crossref
B. Madhu Krishna, Sanjib Chaudhary, Dipti Ranjan Mishra, Sanoj K. Naik, S. Suklabaidya, A. K. Adhya & Sandip K. Mishra. (2018) Estrogen receptor α dependent regulation of estrogen related receptor β and its role in cell cycle in breast cancer. BMC Cancer 18:1.
Crossref
Crossref
Inamul Haque, Arnab Ghosh, Seth Acup, Snigdha Banerjee, Kakali Dhar, Amitabha Ray, Sandipto Sarkar, Suman Kambhampati & Sushanta K. Banerjee. (2018) Leptin-induced ER-α-positive breast cancer cell viability and migration is mediated by suppressing CCN5-signaling via activating JAK/AKT/STAT-pathway. BMC Cancer 18:1.
Crossref
Crossref
Meera Nair, Sardul Singh Sandhu & Anil Kumar Sharma. (2018) Cancer molecular markers: A guide to cancer detection and management. Seminars in Cancer Biology 52, pages 39-55.
Crossref
Crossref
Ramit Singla, Kunj Bihari Gupta, Shishir Upadhyay, Monisha Dhiman & Vikas Jaitak. (2018) Design, synthesis and biological evaluation of novel indole-benzimidazole hybrids targeting estrogen receptor alpha (ER-α). European Journal of Medicinal Chemistry 146, pages 206-219.
Crossref
Crossref
Trang H. Luu, Jean-Marie Bard, Delphine Carbonnelle, Chloé Chaillou, Jean-Michel Huvelin, Christine Bobin-Dubigeon & Hassan Nazih. (2017) Lithocholic bile acid inhibits lipogenesis and induces apoptosis in breast cancer cells. Cellular Oncology 41:1, pages 13-24.
Crossref
Crossref
Xuan Li, Danian Dai, Bo Chen, Hailin Tang, Xiaoming Xie & Weidong Wei. (2018) Clinicopathological and Prognostic Significance of Cancer Antigen 15-3 and Carcinoembryonic Antigen in Breast Cancer: A Meta-Analysis including 12,993 Patients. Disease Markers 2018, pages 1-15.
Crossref
Crossref
Yasset Perez-Riverol, Max Kuhn, Juan Antonio Vizcaíno, Marc-Phillip Hitz & Enrique Audain. (2017) Accurate and fast feature selection workflow for high-dimensional omics data. PLOS ONE 12:12, pages e0189875.
Crossref
Crossref
Martin P. Ogrodzinski, Jamie J. Bernard & Sophia Y. Lunt. (2017) Deciphering metabolic rewiring in breast cancer subtypes. Translational Research 189, pages 105-122.
Crossref
Crossref
G. E. Morozevich, N. I. Kozlova, O. Y. Susova, A. Y. Lupatov & A. E. Berman. (2017) Hyperexpression of integrin α5β1 promotes resistance of MCF-7 human breast carcinoma cells to doxorubicin via ERK protein kinase down-regulation. Biochemistry (Moscow) 82:9, pages 1017-1024.
Crossref
Crossref
Antonis Giakountis, Panagiotis Moulos, Michalis E. Sarris, Pantelis Hatzis & Iannis Talianidis. (2017) Smyd3-associated regulatory pathways in cancer. Seminars in Cancer Biology 42, pages 70-80.
Crossref
Crossref
Eunyoung Lee, Chung Gi Lee, Joung-Han Yim, Hong-Kum Lee & Suhkneung Pyo. (2016) Ramalin-Mediated Apoptosis Is Enhanced by Autophagy Inhibition in Human Breast Cancer Cells. Phytotherapy Research 30:3, pages 426-438.
Crossref
Crossref
Michael J. Duffy, Siun Walsh, Enda W. McDermott & John Crown. 2015.
1
23
.
Matthew Brennan & Bora Lim. 2015. Advances in Cancer Biomarkers. Advances in Cancer Biomarkers
327
337
.
Lei Zhang, Yantao Han, Qixiao Jiang, Chunbo Wang, Xuehong Chen, Xiaoguang Li, Fuming Xu, Yuqi Jiang, Qiang Wang & Wenfang Xu. (2015) Trend of Histone Deacetylase Inhibitors in Cancer Therapy: Isoform Selectivity or Multitargeted Strategy. Medicinal Research Reviews 35:1, pages 63-84.
Crossref
Crossref
Miao Wang, Anders Bonde Jensen, Soeren Smith Morgen, Chun Sen Wu, Ming Sun, Haisheng Li, Benny Dahl & Cody Eric Bünger. (2014) Survival Analysis of Breast Cancer Subtypes in Patients With Spinal Metastases. Spine 39:19, pages 1620-1627.
Crossref
Crossref
Michael J Duffy, Patricia M McGowan, Nadia Harbeck, Christoph Thomssen & Manfred Schmitt. (2014) uPA and PAI-1 as biomarkers in breast cancer: validated for clinical use in level-of-evidence-1 studies. Breast Cancer Research 16:4.
Crossref
Crossref
Jun-Feng Shi, Nan Yang, Hai-Jian Ding, Jie-Xin Zhang, Mei-Ling Hu, Yan Leng, Xiao Han & Yu-Jie Sun. (2014) ERα directly activated the MDR1 transcription to increase paclitaxel-resistance of ERα-positive breast cancer cells in vitro and in vivo. The International Journal of Biochemistry & Cell Biology 53, pages 35-45.
Crossref
Crossref
Federico Ambrogi, Marco Fornili, Patrizia Boracchi, Marco Trerotola, Valeria Relli, Pasquale Simeone, Rossana La Sorda, Rossano Lattanzio, Patrizia Querzoli, Massimo Pedriali, Mauro Piantelli, Elia Biganzoli & Saverio Alberti. (2014) Trop-2 Is a Determinant of Breast Cancer Survival. PLoS ONE 9:5, pages e96993.
Crossref
Crossref
Nicholas C. Dracopoli & Katie Streicher. 2014. Genomic Biomarkers for Pharmaceutical Development. Genomic Biomarkers for Pharmaceutical Development
23
49
.
RUPNINDER SANDHU, ASHLEY G. RIVENBARK & WILLIAM B. COLEMAN. (2012) Loss of post-transcriptional regulation of DNMT3b by microRNAs: A possible molecular mechanism for the hypermethylation defect observed in a subset of breast cancer cell lines. International Journal of Oncology 41:2, pages 721-732.
Crossref
Crossref
Asit K Paul & Richard B Schwab. (2012) Efficacy and pharmacogenomic biomarkers in breast cancer. Biomarkers in Medicine 6:2, pages 211-221.
Crossref
Crossref
A. Phinyomark, S. Jitaree, P. Phukpattaranont & P. Boonyapiphat. (2012) Texture Analysis of Breast Cancer Cells in Microscopic Images Using Critical Exponent Analysis Method. Procedia Engineering 32, pages 232-238.
Crossref
Crossref
Rupninder Sandhu, Ashley G. Rivenbark & William B. Coleman. (2011) Enhancement of chemotherapeutic efficacy in hypermethylator breast cancer cells through targeted and pharmacologic inhibition of DNMT3b. Breast Cancer Research and Treatment 131:2, pages 385-399.
Crossref
Crossref
Michael J. Duffy, Norma O’Donovan & John Crown. (2011) Use of molecular markers for predicting therapy response in cancer patients. Cancer Treatment Reviews 37:2, pages 151-159.
Crossref
Crossref
Emily Sonestedt & Elisabet Wirfält. (2010) Enterolactone and breast cancer: methodological issues may contribute to conflicting results in observational studies. Nutrition Research 30:10, pages 667-677.
Crossref
Crossref
Maria P Pavlou, Vathany Kulasingam, Edward R Sauter, Beth Kliethermes & Eleftherios P Diamandis. (2010) Nipple Aspirate Fluid Proteome of Healthy Females and Patients with Breast Cancer. Clinical Chemistry 56:5, pages 848-855.
Crossref
Crossref
Sondes Karray-Chouayekh, Fatma Trifa, Abdelmajid Khabir, Nouredine Boujelbane, Tahia Sellami-Boudawara, Jamel Daoud, Mounir Frikha, Rachid Jlidi, Ali Gargouri & Raja Mokdad-Gargouri. (2009) Aberrant methylation of RASSF1A is associated with poor survival in Tunisian breast cancer patients. Journal of Cancer Research and Clinical Oncology 136:2, pages 203-210.
Crossref
Crossref
Hugo Arias-Pulido, Harriet O. Smith, Nancy E. Joste, Therese Bocklage, Clifford R. Qualls, Allison Chavez, Eric R. Prossnitz & Claire F. Verschraegen. (2009) Estrogen and progesterone receptor status and outcome in epithelial ovarian cancers and low malignant potential tumors. Gynecologic Oncology 114:3, pages 480-485.
Crossref
Crossref
Mirjam Froehlicher, Anja Liedtke, Ksenia Groh, Hernán López-Schier, Stephan C.F. Neuhauss, Helmut Segner & Rik I.L. Eggen. (2009) Estrogen receptor subtype β2 is involved in neuromast development in zebrafish (Danio rerio) larvae. Developmental Biology 330:1, pages 32-43.
Crossref
Crossref
Emily Sonestedt, Malin I.L. Ivarsson, Sophia Harlid, Ulrika Ericson, Bo Gullberg, Joyce Carlson, Håkan Olsson, Herman Adlercreutz & Elisabet Wirfält. (2009) The Protective Association of High Plasma Enterolactone with Breast Cancer Is Reasonably Robust in Women with Polymorphisms in the Estrogen Receptor α and β Genes. The Journal of Nutrition 139:5, pages 993-1001.
Crossref
Crossref
Sondes Karray-Chouayekh, Fatma Trifa, Abdelmajid Khabir, Nouredine Boujelbane, Tahia Sellami-Boudawara, Jamel Daoud, Mounir Frikha, Ali Gargouri & Raja Mokdad-Gargouri. (2009) Clinical Significance of Epigenetic Inactivation of hMLH1 and BRCA1 in Tunisian Patients with Invasive Breast Carcinoma. Journal of Biomedicine and Biotechnology 2009, pages 1-7.
Crossref
Crossref
Catharine M Sturgeon, Michael J Duffy, Ulf-Håkan Stenman, Hans Lilja, Nils Brünner, Daniel W Chan, Richard Babaian, Robert C BastJr.Jr., Barry Dowell, Francisco J Esteva, Caj Haglund, Nadia Harbeck, Daniel F Hayes, Mads Holten-Andersen, George G Klee, Rolf Lamerz, Leendert H Looijenga, Rafael Molina, Hans Jørgen Nielsen, Harry Rittenhouse, Axel Semjonow, Ie-Ming Shih, Paul Sibley, György Sölétormos, Carsten Stephan, Lori Sokoll, Barry R Hoffman & Eleftherios P Diamandis. (2008) National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers. Clinical Chemistry 54:12, pages e11-e79.
Crossref
Crossref
Michael J Duffy & John Crown. (2008) A Personalized Approach to Cancer Treatment: How Biomarkers Can Help. Clinical Chemistry 54:11, pages 1770-1779.
Crossref
Crossref
Emily Sonestedt, Signe Borgquist, Ulrika Ericson, Bo Gullberg, Håkan Olsson, Herman Adlercreutz, Göran Landberg & Elisabet Wirfält. (2008) Enterolactone Is Differently Associated with Estrogen Receptor β–Negative and –Positive Breast Cancer in a Swedish Nested Case-Control Study. Cancer Epidemiology, Biomarkers & Prevention 17:11, pages 3241-3251.
Crossref
Crossref
E McKiernan, K O'Brien, N Grebenchtchikov, A Geurts-Moespot, A M Sieuwerts, J W M Martens, V Magdolen, D Evoy, E McDermott, J Crown, F C G J Sweep & M J Duffy. (2008) Protein kinase Cδ expression in breast cancer as measured by real-time PCR, western blotting and ELISA. British Journal of Cancer 99:10, pages 1644-1650.
Crossref
Crossref
P Lagiou, C-C Hsieh, D Trichopoulos, H-O Adami, P Hall, L Chie & A Ekbom. (2008) Neonatal growth and breast cancer risk in adulthood. British Journal of Cancer 99:9, pages 1544-1548.
Crossref
Crossref
E. Sonestedt, S. Borgquist, U. Ericson, B. Gullberg, G. Landberg, H. Olsson & E. Wirfalt. (2008) Plant foods and oestrogen receptor - and -defined breast cancer: observations from the Malmo Diet and Cancer cohort. Carcinogenesis 29:11, pages 2203-2209.
Crossref
Crossref
Dmitry A. Turbin, Samuel Leung, Maggie C. U. Cheang, Hagen A. Kennecke, Kelli D. Montgomery, Steven McKinney, Diana O. Treaba, Niki Boyd, Lynn C. Goldstein, Sunil Badve, Allen M. Gown, Matt van de Rijn, Torsten O. Nielsen, C. Blake Gilks & David G. Huntsman. (2007) Automated quantitative analysis of estrogen receptor expression in breast carcinoma does not differ from expert pathologist scoring: a tissue microarray study of 3,484 cases. Breast Cancer Research and Treatment 110:3, pages 417-426.
Crossref
Crossref
Eiji Sunami, Masaru Shinozaki, Myung-Shin Sim, Sandy L Nguyen, Anh-Thu Vu, Armando E Giuliano & Dave SB Hoon. (2008) Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors. Breast Cancer Research 10:3.
Crossref
Crossref
P.M. McGowan, E. McKiernan, F. Bolster, B.M. Ryan, A.D.K. Hill, E.W. McDermott, D. Evoy, N. O'Higgins, J. Crown & M.J. Duffy. (2008) ADAM-17 predicts adverse outcome in patients with breast cancer. Annals of Oncology 19:6, pages 1075-1081.
Crossref
Crossref
Claudia Casarsa, Saro Oriana & Danila Coradini. (2008) The Controversial Clinicobiological Role of Breast Cancer Stem Cells. Journal of Oncology 2008, pages 1-12.
Crossref
Crossref
Marcia S. Driscoll & Jane M. Grant-Kels. (2007) Hormones, nevi, and melanoma: An approach to the patient. Journal of the American Academy of Dermatology 57:6, pages 919-931.
Crossref
Crossref
K.J. Pawlak & J.P. Wiebe. (2007) Regulation of estrogen receptor (ER) levels in MCF-7 cells by progesterone metabolites. The Journal of Steroid Biochemistry and Molecular Biology 107:3-5, pages 172-179.
Crossref
Crossref
Michael J. Duffy. (2007) Role of tumor markers in patients with solid cancers: A critical review. European Journal of Internal Medicine 18:3, pages 175-184.
Crossref
Crossref
Abhik Bandyopadhyay, Long Wang, Shiau Hui Chin & Lu-Zhe Sun. (2007) Inhibition of Skeletal Metastasis by Ectopic ERα Expression in ERα-Negative Human Breast Cancer Cell Lines. Neoplasia 9:2, pages 113-118.
Crossref
Crossref